Impact ledger
NextCure, Inc. (NXTC)
6 events mapped to this ticker since 2026-06-25.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-07-14 | share_count | Bullish | — | 0.70 |
| 2026-07-14 | net_debt | Bullish | — | 0.70 |
| 2026-07-14 | revenue | Bullish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-07-17 | Event | Merger financing and potential dilution. The private placement is in connection with the merger, suggesting it's a key component of the combined entity's capitalization strategy. | watch | 1-3m | 0.70 |
| 2026-07-17 | Event | Strategic acquisition of pipeline assets, potential for synergies, dilution from all-stock merger and concurrent private placement, integration risks. | mixed | 1-5y | 0.80 |
| 2026-07-17 | Event | Regulatory filing indicating an impending business combination. The specific terms and counterparty are unknown, leading to uncertainty. | watch | 1-3m | 0.80 |
| 2026-07-17 | Event | Direct M&A announcement, potential for acquisition premium or deal uncertainty. | watch | 1-3m | 0.90 |
| 2026-07-14 | Event | Acquisition of Avere Therapeutics, Inc. via an all-stock transaction. NextCure shareholders will own a portion of the combined entity. The combined company will focus on Avere's pipeline. | mixed | 3-12m | 0.80 |
| 2026-06-25 | Event | The approval of an amended omnibus incentive plan suggests potential changes in executive and employee compensation structures, which could impact share-based compensation expenses and potentially share dilution over time. The 'watch' direction is due to the lack of specific details on the amendment | watch | 1-3m | 0.30 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for NXTC, start a trial or view the NXTC entity page.